CD95
- Known as:
- CD95
- Catalog number:
- 6L95
- Product Quantity:
- 1mg
- Category:
- -
- Supplier:
- Hytest
- Gene target:
- CD95
Related genes to: CD95
- Gene:
- FAS NIH gene
- Name:
- Fas cell surface death receptor
- Previous symbol:
- FAS1, APT1, TNFRSF6
- Synonyms:
- CD95, APO-1
- Chromosome:
- 10q23.31
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-25
- Date modifiied:
- 2019-04-23
Related products to: CD95
Related articles to: CD95
- Peripheral arterial disease (PAD) is associated with intermittent claudication (IC), leading to a lower quality of life. Although extract (GbE) has been investigated for the treatment of IC, its clinical efficacy remains controversial. This study aimed to evaluate the efficacy and safety of high-dose, long-term GbE therapy in patients with PAD and IC. - Source: PubMed
Publication date: 2026/08/24
Kim OnyouLee Seung HunKim Jang YongKim WonhoLee Han CheolRoh Ji WoongJoh Jin HyeonPark Sang-HoShin SanghoonMd Sung-Hun ParkKim WoohyeunAhn Hyung JoonLee Ho KyunKim Sang HoonHer Sung-HoRha Seung-WoonYu Cheol Woong - To describe the conventional sonographic features of oncocytic thyroid neoplasms (OTNs) and compare them with those of papillary thyroid carcinoma (PTC), nodular goiter (NG), and three follicular-pattern comparator groups: follicular adenoma (FA), follicular thyroid carcinoma (FTC), and follicular variant of papillary thyroid carcinoma (FVPTC). - Source: PubMed
Publication date: 2026/09/22
Li ChuanyangZhu TingyuZheng XiaojuanChen ZhuominZhu ChaoLi Yiying - Canakinumab induces clinical remission in a substantial proportion of patients with systemic juvenile idiopathic arthritis (sJIA), although not all achieve a complete response. However, tapering and withdrawal frequently lead to disease flares. This study aimed to identify serum and transcriptomic biomarkers that predict successful or unsuccessful tapering of canakinumab in sJIA. - Source: PubMed
Publication date: 2026/09/22
Hinze TanjaHinze Claas HKessel ChristophVerweyen Emely LSaers MelanieFuehner SabrinaSchleifenbaum SusanneHartmann WolfgangTrautmann MarcelHuge AndreasFarady Christopher JMcCreddin SuzanneFoell Dirk - Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease with limited treatments and a need for glucocorticoid-sparing therapies. Zetomipzomib is a selective immunoproteasome inhibitor in development for AIH. - Source: PubMed
Publication date: 2026/08/26
Lammert Craig SWeinberg Ethan MSclair Seth NFontana Robert JAnand Neel KAnderl Janet LBade DavidDesai ShraddhaKirk Christopher JLam DianaLowe EricMuchamuel TonyPalaniswamy KiruthiPeterson RachelRay KathrynTo ZungTuch Brian BWhang Jennifer AGoel Aparna - Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferative keratinocytes and activated Th17/Th1 lymphocytes, which sustain a self-perpetuating cycle by releasing pro-inflammatory cytokines. The RNA-binding protein (RBP) Human Antigen R (HuR) stabilizes many of these cytokine mRNAs, contributing to disease progression. This study aims to investigate the role of the HuR protein in psoriasis and modulate its activity to develop novel therapeutic strategies. - Source: PubMed
Publication date: 2026/09/17
Paladino DalilaAtene Claudio GPaganin MartinaPalazzo ElisabettaQuadri MarikaMarconi AlessandraTace DorianLazzari LorenzaTrombetta ElenaRoccuzzo MichelaTornese MartaFaiulo AlessiaReggiani Bonetti LucaManfredini MarcoNazzaro GianlucaMarzano Angelo VArosio DanielaSeneci PierfaustoProvenzani AlessandroD'Agostino Vito GLotti Roberta